TNFRSF10B and cancer: Recent studies have shown that TRAIL resistance can be reversed by upregulating DR5 with chemotherapeutic agents [51, 52] and ER stress can trigger the augment of DR5 level in a range of human cancers through the transactivation of the transcription factor CHOP [32].